Audit 364348

FY End
2024-12-31
Total Expended
$5.49M
Findings
0
Programs
2
Organization: Aids Vaccine Advocacy Coalition (NY)
Year: 2024 Accepted: 2025-08-15
Auditor: Eisneramper LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
98.001 Usaid Foreign Assistance for Programs Overseas $327,708 Yes 0
93.855 Allergy and Infectious Diseases Research $84,382 - 0

Contacts

Name Title Type
PJUPN27NDK71 Abigail Smith Auditee
9177963505 William Epstein Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of AVAC under programs of the federal government for the year ended December 31, 2024. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of AVAC, it is not intended to and does not present the financial position, changes in net assets, or cash flows of AVAC. De Minimis Rate Used: N Rate Explanation: AVAC has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.